|
Indian Journal of Dermatology, Venereology and Leprology
Medknow Publications on behalf of The Indian Association of Dermatologists, Venereologists and Leprologists (IADVL)
ISSN: 0378-6323 EISSN: 0378-6323
Vol. 69, No. 3, 2003, pp. 209-211
|
Bioline Code: dv03004
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
Indian Journal of Dermatology, Venereology and Leprology, Vol. 69, No. 3, 2003, pp. 209-211
en |
Study - Diltiazem vs. nifedipine in chilblains: A clinical trial
A. K. Patra, A. L. Das, P. Ramadasan
Abstract
Background: The treatment of chilblains remains unsatisfactory. Nifedipine in higher doses remains the mainstay of treatment. Aims: To compare the efficacy of diltiazem with that of nifedipine, and to determine the efficacy of nifedipine in lower doses, 36 chilblains cases were studied. Material and Methods: Group A (12 patients) was treated with diltiazem 60 mg thrice daily, and Group B (24 patients) with 10 mg nifedipine thrice daily till complete relief and then maintained on a sustained release preparation of nifedipine 20 mg twice daily. Results: Two patients in Group A showed complete relief in 7 days, and 3 patients in about 21 days, but in 7 cases there was little or no response. In group B, 21 cases showed 80-90% relief by the fourteenth day. Conclusions: We conclude that nifedipine remains the drug of choice in chilblains but can be used in a smaller dosage in the Indian population. Diltiazem is less effective in the conventional dose, which may be optimized.
Keywords
Calcium channel blockers
|
|
© Copyright 2003 Indian Journal of Dermatology, Venereology & Leprology. Free full text also at http://www.ijdvl.com Alternative site location: http://www.ijdvl.com
|
|